Yasutaka Hoashi

This inventor holds 29 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 14 EPO patents, primarily in Heterocyclic Compounds. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasutaka Hoashi. Retrieved from https://idiyas.com/inventor/yasutaka-hoashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 9)

% Patents Active = 75.9

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 14 (Patent Applications = 17)

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 74(Granted Patents)

Location History:

Osaka, JP (2011 - 2014)
Kanagawa, JP (2013 - 2024)

Company Filing History:

29 out of 1,226

Takeda Pharmaceutical Company Limited

patents

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Cationic Lipids

Tricyclic Compounds

Pyrrolo[1,2-c]Imidazole

Orexin Receptor Agonists

Pharmaceutical Use

Medical Applications

Bicyclic Compounds

Sulfonamide Derivatives

Excessive Sleepiness

Cataplexy Treatment

Derivatives

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662453 - Heterocyclic compound and use thereof (2026-06-23),

2. 12534471 - Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof (2026-01-27),

3. 12479791 - CATIONIC LIPID (2025-11-25),

4. 12448377 - Heterocyclic compound (2025-10-21),

5. 12421188 - Heterocyclic compound and use thereof (2025-09-23),

6. 12415782 - Heterocyclic compound and use thereof (2025-09-16),

7. 12404237 - Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1'-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives (2025-09-02),

8. 12091410 - Heterocyclic compound (2024-09-17),

9. 12077522 - Heterocyclic compound and application thereof (2024-09-03),

10. 12071434 - Heterocyclic compound (2024-08-27),

11. 11993570 - Cationic lipids (2024-05-28),

12. 11987586 - Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists (2024-05-21),

13. 11655241 - Heterocyclic compound and use thereof (2023-05-23),

14. 11440883 - Heterocyclic compound and use thereof (2022-09-13),

15. 11319286 - Heterocyclic compound and application thereof (2022-05-03),

Title: Inventor Yasutaka Hoashi - Revolutionizing Technology in Osaka

Introduction: Yasutaka Hoashi is a visionary inventor based in Osaka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hoashi's recent patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable technology for healthcare monitoring, and sustainable energy solutions for urban environments.

Career Highlights: With over two decades of experience in research and development, Hoashi has led numerous successful projects that have resulted in cutting-edge products and technologies. His expertise spans across various sectors, including robotics, telecommunications, and renewable energy.

Collaborations: Throughout his career, Hoashi has collaborated with leading tech companies, research institutions, and universities both in Japan and internationally. These partnerships have been instrumental in bringing his innovative ideas to life and pushing the boundaries of technological advancement.

Conclusion: Yasutaka Hoashi's relentless pursuit of innovation and his passion for creating a positive impact through technology have solidified his reputation as a pioneering inventor in Osaka and beyond.

Profile summary based on public USPTO records.